After founding one unicorn company, this AI pioneer is doing it again

After founding the "Google for LLMs," You.com, Richard Socher's next company, Recursive AI, could automate AI research itself ...
Infosecurity Magazine

How Security Leaders Can Safeguard Against Vibe Coding Security Risks

Infosecurity outlines key recommendations for CISOs and security teams to implement safeguards for AI-assisted coding ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Nasdaq

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Insider Activity

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Benzinga.com

Recursion Pharmaceuticals Stock Short Interest Report | NASDAQ:RXRX | Benzinga

Web site created using create-react-app Short interest in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) decreased during the last reporting period, falling from 173.17M to 168.52M. This put 34.3% of the ...